Trial Profile
Gastrointestinal behavior of abirateronacetaat in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Sep 2023
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary)
- Indications Breast cancer; Ovarian cancer; Prostate cancer
- Focus Pharmacokinetics
- 29 Sep 2023 Status changed from recruiting to completed.
- 22 Aug 2014 New trial record